GDF15 and COVID-19: On the contrary, a study by Delaye et al. reported lower median levels of GDF-15 in COVID-19 patients compared to SARS-CoV-2-negative patients [23], and another study implied that there is no association between GDF-15 and the need for hospitalization in SARS-CoV-2 patients [24].